HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease.

Abstract
The excitotoxin quinolinic acid (QUIN) is synthesized through the kynurenine pathway (KP) by activated monocyte lineage cells. QUIN is likely to play a role in the pathogenesis of several major neuroinflammatory diseases including Alzheimer's disease (AD). The presence of reactive astrocytes, astrogliosis, increased oxidative stress and inflammatory cytokines are important pathological hallmarks of AD. We assessed the stimulatory effects of QUIN at low physiological to high excitotoxic concentrations in comparison with the cytokines commonly associated with AD including IFN-gamma and TNF-alpha on primary human astrocytes. We found that QUIN induces IL-1beta expression, a key mediator in AD pathogenesis, in human astrocytes. We also explored the effect of QUIN on astrocyte morphology and functions. At low concentrations, QUIN treatment induced concomitantly a marked increase in glial fibrillary acid protein levels and reduction in vimentin levels compared to controls; features consistent with astrogliosis. At pathophysiological concentrations QUIN induced a switch between structural protein expressions in a dose dependent manner, increasing VIM and concomitantly decreasing GFAP expression. Glutamine synthetase (GS) activity was used as a functional metabolic test for astrocytes. We found a significant dose-dependent reduction in GS activity following QUIN treatment. All together, this study showed that QUIN is an important factor for astroglial activation, dysregulation and cell death with potential relevance to AD and other neuroinflammatory diseases.
AuthorsKa Ka Ting, Bruce J Brew, Gilles J Guillemin
JournalJournal of neuroinflammation (J Neuroinflammation) Vol. 6 Pg. 36 (Dec 10 2009) ISSN: 1742-2094 [Electronic] England
PMID20003262 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amyloid beta-Peptides
  • Glial Fibrillary Acidic Protein
  • Interleukin-1beta
  • RNA, Messenger
  • Transforming Growth Factor alpha
  • Tumor Necrosis Factor-alpha
  • Vimentin
  • Interferon-gamma
  • Quinolinic Acid
Topics
  • Alzheimer Disease (metabolism, pathology)
  • Amyloid beta-Peptides (metabolism, toxicity)
  • Animals
  • Astrocytes (cytology, drug effects, metabolism)
  • Cell Proliferation
  • Cells, Cultured
  • Glial Fibrillary Acidic Protein (genetics, metabolism)
  • Humans
  • Interferon-gamma (genetics, metabolism)
  • Interleukin-1beta (genetics, metabolism)
  • Quinolinic Acid (pharmacology)
  • RNA, Messenger (genetics, metabolism)
  • Rats
  • Transforming Growth Factor alpha (genetics, metabolism)
  • Tumor Necrosis Factor-alpha (genetics, metabolism)
  • Vimentin (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: